Alps Advisors Inc Amarin Corp Plcuk Transaction History

Alps Advisors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.09 - $1.67 $16,905 - $25,901	-15,510 Reduced 6.59%	220,005 $240,000
Q2 2022 Aug 11, 2022	BUY	$1.13 - $3.69 $266,131 - $869,050	235,515 New	235,515 $351,000
Q4 2018 Feb 04, 2019	SELL	$12.41 - $22.98 $6.45 Million - $11.9 Million	-519,534 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$2.45 - $16.27 $228,947 - $1.52 Million	93,448 Added 21.93%	519,534 $8.45 Million
Q2 2018 Aug 02, 2018	BUY	$2.68 - $3.48 $337,728 - $438,542	126,018 Added 42.0%	426,086 $1.32 Million
Q2 2018 Jul 25, 2018	BUY	$2.68 - $3.48 $804,182 - $1.04 Million	300,068 New	300,068 $1.2 Million
Q1 2018 May 01, 2018	SELL	$2.99 - $4.44 $897,203 - $1.33 Million	-300,068 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$3.06 - $4.09 $918,208 - $1.23 Million	300,068	300,068 $1.2 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.